文献速递鼻科

慢性鼻窦炎手术嗅觉结局的最小临床重要差异定义

Defining the minimal clinically important difference for olfactory outcomes in the surgical treatment of chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-05-26

本研究基于多中心290例接受内镜鼻窦手术的慢性鼻窦炎成人患者,采用分布法和锚定法确定Brief Smell Identification Test(BSIT)的最小临床重要差异(MCID)。结果显示整体MCID标准值为1.0,基线嗅觉障碍患者术后BSIT平均变化显著超过该值,且与鼻息肉无关。

要点

  • BSIT的MCID标准值为1.0,适用于接受内镜鼻窦手术的慢性鼻窦炎异质性患者。
  • 基线嗅觉障碍患者术后BSIT平均变化显著超过MCID,无论是否伴鼻息肉。
  • 术前嗅觉障碍与鼻息肉显著相关(χ2=35.0;p<0.001)。

核心结论

  • 对于接受内镜鼻窦手术的慢性鼻窦炎异质性患者,BSIT评分变化至少1.0个绝对值单位可定义为有临床意义的改变。
  • 显著超过该MCID标准可能仅限于基线存在嗅觉障碍的慢性鼻窦炎患者,无论是否伴鼻息肉。

研究设计与样本

  • 多中心前瞻性队列研究,纳入2011年3月至2015年6月间290例因药物难治性慢性鼻窦炎接受内镜鼻窦手术的成人患者。
  • 患者术前及术后完成BSIT评估,采用分布法和锚定法分析确定MCID。

主要发现

  • 92例(约32%)患者术前存在嗅觉障碍(BSIT<9),与鼻息肉显著相关(χ2=35.0;p<0.001)。
  • 效应量分布法确定整体MCID标准值为1.0,介于小效应与中等效应之间(范围0.61-1.52)。
  • 嗅觉障碍患者术后BSIT平均变化ΔM=2.28(p<0.001),其中伴鼻息肉者(n=54)ΔM=2.52(p<0.001),不伴鼻息肉者(n=38)ΔM=1.95(p<0.001),均显著超过MCID标准。
  • 锚定法结合回归模型证实MCID值与术后嗅觉特异性问卷反应变化相关(p<0.001)。

关键数值与推荐

  • BSIT的MCID标准值为1.0个绝对值单位,适用于接受内镜鼻窦手术的慢性鼻窦炎异质性患者。
  • 基线嗅觉障碍患者术后BSIT平均变化ΔM=2.28(p<0.001),伴鼻息肉者ΔM=2.52(p<0.001),不伴鼻息肉者ΔM=1.95(p<0.001)。

临床怎么用

  • 在慢性鼻窦炎患者接受内镜鼻窦手术的嗅觉结局评估中,BSIT评分变化至少1.0个绝对值单位可视为有临床意义的改善。
  • 基线存在嗅觉障碍的患者术后BSIT变化可能显著超过MCID标准,无论是否伴鼻息肉。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Olfactory dysfunction is a common and defining symptom of chronic rhinosinusitis (CRS). Many measures of olfactory dysfunction in CRS are limited by scoring criteria defined within general populations with interpretations of statistical significance to infer clinically meaningful improvement. In this investigation we define a minimal clinically important difference (MCID) for the Brief Smell Identification Test (BSIT) in CRS patients electing endoscopic sinus surgery (ESS). METHODS: A multicenter cohort of 290 adult patients electing ESS for medically recalcitrant CRS were prospectively enrolled between March 2011 and June 2015 and completed BSIT evaluations before and after ESS. Distribution and anchor-based analytic approaches were utilized to define MCID values of the BSIT across patient cofactors. RESULTS: A total of 92 (∽32%) patients were found to have preoperative olfactory dysfunction (BSIT <9), significantly associated with nasal polyposis (χ2 = 35.0; p < 0.001). The effect-size distribution-based approach identified 1.0 as a MCID criterion value between "small" and "medium" effect (range, 0.61-1.52) overall. Significant mean postoperative change (ΔM) was reported for patients with olfactory dysfunction (ΔM = 2.28; p < 0.001), both with (n = 54; ΔM = 2.52; p < 0.001) and without (n = 38; ΔM = 1.95; p < 0.001) nasal polyposis, significantly exceeding the MCID criterion. Anchor-based approaches with regression modeling confirmed associations between MCID values and postoperative changes to olfactory-specific survey responses (p < 0.001). CONCLUSION: Clinically meaningful change in BSIT scores may be defined as an absolute value difference of at least 1.0 unit for heterogeneous patients electing ESS for CRS. Significantly exceeding this criterion may be restricted to CRS patients with baseline olfactory dysfunction, regardless of nasal polyposis.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Levy JM, Mace JC, Bodner TE, et al. Defining the minimal clinically important difference for olfactory outcomes in the surgical treatment of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017. PMID: 28556611. doi:10.1002/alr.21964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。